Protein sequencing method and reagents
Abstract
The invention describes methods and reagents useful for sequencing polypeptide molecules. The method comprises affixing a polypeptide to a substrate and contacting the polypeptide with a plurality of probes. Each probe selectively binds to an N-terminal amino acid or an N-terminal amino acid derivative. Probes bound to the polypeptide molecule are then identified before cleaving the N-terminal amino acid or N-terminal amino acid derivative of the polypeptide. Also provided are methods for the sequencing a plurality of polypeptide molecules in a sample and probes specific for N-terminal amino acids or N-terminal amino acid derivatives.
Claims
exact text as granted — not AI-modified1 . A method of sequencing a polypeptide comprising:
a. affixing the polypeptide to a substrate; b. contacting the polypeptide with a plurality of probes, wherein each probe selectively binds to an N-terminal amino acid or a N-terminal amino acid derivative; c. detecting the probe bound to the polypeptide molecule, thereby identifying the N-terminal amino acid of the polypeptide; d. cleaving the N-terminal amino acid or N-terminal amino acid derivative of the polypeptide; and e. repeating steps (b) to (d) to determine the sequence of at least a portion of the polypeptide.
2 . The method of claim 1 , wherein the polypeptide is a single polypeptide molecule.
3 . The method of claim 1 , wherein step b) further comprises derivatizing the N-terminal amino acid of the polypeptide prior to contacting the polypeptide with the plurality of probes.
4 . The method of claim 1 , wherein step a) comprises affixing the polypeptide to the substrate through a C′-terminal carboxyl group or a side chain functional group of the polypeptide.
5 . The method of claim 1 , wherein the polypeptide is covalently affixed to the substrate.
6 . (canceled)
7 . The method of claim 1 , wherein the substrate comprises a plurality of spatially resolved attachment points.
8 . The method of claim 7 , wherein step a) comprises affixing the polypeptide to a spatially resolved attachment point.
9 . The method of claim 1 , wherein the plurality of probes comprises:
a. one or more probes that selectively bind to one of 20 natural proteinogenic amino acids; b. one or more probes that selectively bind to a post-translationally modified amino acid; or c. one or more probes that selectively bind to a derivative of a) or b).
10 . The method of claim 11 , wherein at least one probe comprises an affinity capture reagent and a detectable label.
11 . The method of claim 10 , wherein the step of detecting the probe bound to the polypeptide comprises detecting the detectable label
12 . The method of claim 10 , wherein the affinity capture reagent comprises a polypeptide.
13 . (canceled)
14 . (canceled)
15 . The method of claim 1 , wherein step e) comprises cleaving the N-terminal amino acid or N-terminal amino acid derivative of the polypeptide using Edman degradation.
16 . (canceled)
17 . A method of sequencing a plurality of polypeptide molecules in a sample comprising:
a. affixing the polypeptide molecules in the sample to a plurality of spatially resolved attachment points on a substrate; b. contacting the polypeptides with a plurality of probes, wherein each probe selectively binds to an N-terminal amino acid or a N-terminal amino acid derivative; c. for a plurality of polypeptides molecule that are spatially resolved and affixed to the substrate, identifying the probe bound to each polypeptide; d. cleaving the N-terminal amino acid or N-terminal amino acid derivative of each of the polypeptides; and e. repeating steps b) to d) to determine the sequence of at least a portion of one or more of the plurality of polypeptide molecules that are spatially resolved and affixed to the substrate.
18 . The method of claim 17 , wherein the sample comprises a biological fluid, cell extract or tissue extract.
19 . (canceled)
20 . (canceled)
21 . A probe comprising a variant of a polypeptide wherein the variant binds to an N-terminal amino acid or a N-terminal amino acid derivative with a different selectivity than the polypeptide.
22 . (canceled)
23 . The probe of claim 21 , wherein the polypeptide is a ClpS polypeptide and the variant of the ClpS polypeptide comprises at least 80% sequence identity to SEQ ID NO: 1 or SEQ ID NO: 2.
24 . The probe of claim 23 , wherein the variant comprises one or more mutations at positions that correspond to residues 12 , 13 , 14 , 16 , 17 , 18 , 21 , 40 , 43 , 44 , 76 or 77 as set forth in SEQ ID NO: 1.
25 . The probe of claim 23 , wherein the variant CIpS polypeptide comprises cystein residues at positions that correspond to residues 21 and 40 in SEQ ID NO: 1.
26 . The probe of claim 21 , wherein the variant comprises a polypeptide with at least 80% sequence identify to the polypeptide sequence as set forth in SEQ ID NO: 2 and wherein the variant selectively binds the N-terminal amino acid tryptophan.
27 . The probe of claim 21 , further comprising a detectable label.Join the waitlist — get patent alerts
Track US2017212126A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.